Evaluation of the revised criteria for biological and clinical staging of Alzheimer's disease

Abstract

Background: In the recent update of the Alzheimer's disease (AD) criteria, tau‐PET was introduced as a core biomarker, and its spatial extent was incorporated into the revised biological stages of the disease.

The paper